骨伤药水治疗踝关节骨折术前肿胀疼痛临床 疗效观察

Clinical Efficacy Observation of Bone Trauma Medicinal Liquid in Treating Preoperative Swelling and Pain of Ankle Fracture

摘要: 目的：探究骨伤药水湿敷对踝关节骨折术前肿胀、疼痛的临床治疗效果，为临床缩短踝关节骨折术前准备时间、提高中医救治参与率、增加临床疗效有效性提供参考。方法：选择取2025年7月~2026年3月重庆市大足区中医院骨伤科收治的70例单侧踝关节骨折患者为研究对象，采用随机数字表法分为实验组和对照组各35例。对照组予以口服塞来昔布胶囊联合七叶皂苷钠片 + 50%硫酸镁溶液湿敷治疗，实验组予以口服塞来昔布胶囊联合七叶皂苷钠片 + 骨伤药水湿敷治疗。对比两组患者治疗前后视觉模拟评分(VAS)、肿胀持续时间、消肿速度及不良事件发生率。结果：治疗前两组VAS评分、踝关节肿胀周径差值比较差异无统计学意义(P > 0.05)，具有可比性；治疗后实验组VAS评分为(2.12 ± 0.48)分，显著低于对照组的(4.27 ± 0.73)分，肿胀持续时间为(3.26 ± 0.54) d，短于对照组的(5.18 ± 0.82) d，消肿速度为(0.89 ± 0.16) cm/d，快于对照组的(0.52 ± 0.11) cm/d，组间差异均有统计学意义(P < 0.05)；两组不良事件发生率分别为2.86%、5.71%，差异无统计学意义(P > 0.05)。结论：骨伤药水湿敷联合西药口服能快速缓解踝关节骨折患者术前肿胀、疼痛症状，加速肿胀消退、缩短术前等待时间，且用药安全性良好，值得推广并应用。

Abstract: Objective: To investigate the clinical efficacy of wet compress with bone trauma medicinal liquid on preoperative swelling and pain in ankle fracture patients, and to provide reference for shortening preoperative preparation time, increasing the participation rate of traditional Chinese medicine (TCM) in emergency treatment, and enhancing clinical therapeutic effectiveness. Methods: A total of 70 patients with unilateral ankle fracture admitted to the Department of Orthopedics and Traumatology, Dazu District Hospital of Traditional Chinese Medicine, Chongqing, from July 2025 to March 2026 were selected as the study subjects. They were randomly divided into an experimental group and a control group (35 cases each) using a random number table method. The control group received oral celecoxib capsules combined with aescinate sodium tablets plus wet compress with 50% magnesium sulfate solution, while the experimental group received oral celecoxib capsules combined with aescinate sodium tablets plus wet compress with bone trauma medicinal liquid. The visual analogue scale (VAS) score, duration of swelling, speed of swelling reduction, and incidence of adverse events were compared between the two groups before and after treatment. Results: Before treatment, there was no statistically significant difference in VAS scores and ankle circumference difference between the two groups (P > 0.05), indicating comparability. After treatment, the VAS score in the experimental group was (2.12 ± 0.48) points, significantly lower than (4.27 ± 0.73) points in the control group; the duration of swelling was (3.26 ± 0.54) days, shorter than (5.18 ± 0.82) days in the control group; and the speed of swelling reduction was (0.89 ± 0.16) cm/d, faster than (0.52 ± 0.11) cm/d in the control group. All inter-group differences were statistically significant (P < 0.05). The incidence of adverse events was 2.86% and 5.71% in the two groups respectively, with no statistically significant difference (P > 0.05). Conclusion: Wet compress with bone trauma medicinal liquid combined with oral Western medicine can rapidly relieve preoperative swelling and pain symptoms in ankle fracture patients, accelerate swelling resolution, shorten preoperative waiting time, and demonstrate good medication safety. It is worthy of promotion and clinical application.